Kassira Wealth Management LLC Crispr Therapeutics Ag Transaction History
Kassira Wealth Management LLC
- $104 Billion
- Q3 2025
A detailed history of Kassira Wealth Management LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Kassira Wealth Management LLC holds 15,745 shares of CRSP stock, worth $867,864. This represents 0.98% of its overall portfolio holdings.
Number of Shares
15,745Holding current value
$867,864% of portfolio
0.98%Shares
1 transactions
Others Institutions Holding CRSP
# of Institutions
540Shares Held
69MCall Options Held
3.66MPut Options Held
2.25M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$561 Million4.09% of portfolio
-
Capital International Investors Los Angeles, CA5.59MShares$308 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.68MShares$203 Million0.11% of portfolio
-
State Street Corp Boston, MA3.27MShares$180 Million0.01% of portfolio
-
Ubs Group Ag2.84MShares$157 Million0.02% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.3B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....